NASDAQ:TRDA | Key Financial Ratios | Entrada Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-3010.89-55.47%-71.02%
2026-03-3113.9-49.51%-61.33%
2025-12-3112.53-38.09%-46.96%
2025-09-3014.08-25.06%-30.36%
2025-06-3018.64-16.34%-19.33%
2025-03-3121.885.09%5.94%
2024-12-3111.1512.47%15.31%
2024-09-306.599.91%13.01%
2024-06-305.717.95%24.29%
2024-03-312.384.60%8.72%
2023-12-312.33-1.42%-2.76%
2023-09-302.32-4.49%-8.83%
2023-06-303.1-16.67%-39.81%
2023-03-312.94-16.74%-34.68%
2022-12-319.55-37.54%-44.51%
2022-09-3010.89-32.22%-37.92%
2022-06-3014.05-26.27%-30.36%
2022-03-3117.68-20.35%-23.23%
2021-12-3144.46-16.73%-17.13%
2021-09-3017.26-31.26%57.01%
2021-06-3057.52%
2021-03-3160.84%
2020-12-3111.89-60.93%63.93%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-3112.53-38.09%-46.96%
2024-12-3111.1512.47%15.31%
2023-12-312.33-1.42%-2.76%
2022-12-319.55-37.54%-44.51%
2021-12-3144.46-16.73%-17.13%
2020-12-3111.89-60.93%63.93%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.